# Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine

> **NCT01807234** · PHASE4 · COMPLETED · sponsor: **Johns Hopkins University** · enrollment: 72 (actual)

## Conditions studied

- Migraines

## Interventions

- **DRUG:** Ketorolac
- **DRUG:** Sumatriptan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01807234
- **Lead sponsor:** Johns Hopkins University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-02
- **Primary completion:** 2014-12
- **Final completion:** 2014-12
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2017-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01807234

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01807234, "Comparison of Ketorolac Nasal Spray to Sumatriptan Nasal Spray and Placebo for Acute Treatment of Migraine". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01807234. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*